相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Simultaneous Versus Delayed Resection for Initially Resectable Synchronous Colorectal Cancer Liver Metastases A Prospective, Open-label, Randomized, Controlled Trial
Karim Boudjema et al.
ANNALS OF SURGERY (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The impact of hepatic arterial infusion pump chemotherapy on hepatic recurrences and survival in patients with resected colorectal liver metastases
Florian E. Buisman et al.
HPB (2020)
Hepatic artery infusion pumps
Cornelius A. Thiels et al.
JOURNAL OF SURGICAL ONCOLOGY (2020)
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer
T. Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Liver transplantation for colorectal liver metastasis
Eve Simoneau et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2019)
FOLFOXIRI Plus Panitumumab As First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The Randomized, Open-Label, Phase II VOLFI Study (AIO KRK0109)
Dominik P. Modest et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
Michael J. Overman et al.
LANCET ONCOLOGY (2017)
Updated Long-Term Survival for Patients With Metastatic Colorectal Cancer Treated With Liver Resection Followed by Hepatic Arterial Infusion and Systemic Chemotherapy
Nancy E. Kemeny et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90
Jin-Yao Teo et al.
HPB (2016)
Patterns of metastasis in colon and rectal cancer
Matias Riihimaki et al.
SCIENTIFIC REPORTS (2016)
Phase II Trial of Hepatic Artery Infusional and Systemic Chemotherapy for Patients With Unresectable Hepatic Metastases From Colorectal Cancer Conversion to Resection and Long-term Outcomes
Michael I. D'Angelica et al.
ANNALS OF SURGERY (2015)
Hepatic Parenchymal Preservation Surgery: Decreasing Morbidity and Mortality Rates in 4,152 Resections for Malignancy
T. Peter Kingham et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2015)
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
Chiara Cremolini et al.
LANCET ONCOLOGY (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Systematic review and meta-analysis of hepatic arterial infusion chemotherapy as bridging therapy for colorectal liver metastases
Daniel L. Chan et al.
SURGICAL ONCOLOGY-OXFORD (2015)
Pattern of distant metastases in colorectal cancer: a SEER based study
Miaozhen Qiu et al.
ONCOTARGET (2015)
Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial
T. Gruenberger et al.
ANNALS OF ONCOLOGY (2015)
Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Colorectal Liver Metastases: A Meta-Analysis
Anthony J. Zacharias et al.
PLOS ONE (2015)
Hepatic arterial infusional chemotherapy in the management of colorectal cancer liver metastases
Alexandre Doussot et al.
HEPATIC ONCOLOGY (2015)
Patterns of Recurrence After Liver Transplantation for Nonresectable Liver Metastases from Colorectal Cancer
Morten Hagness et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
Fotios Loupakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Effect on Outcome of Recurrence Patterns After Hepatectomy for Colorectal Metastases
Michael D'Angelica et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Microsatellite Instability in Colorectal Cancer
C. Richard Boland et al.
GASTROENTEROLOGY (2010)
Survival after Hepatic Resection for Metastatic Colorectal Cancer: Trends in Outcomes for 1,600 Patients during Two Decades at a Single Institution
Michael G. House et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2010)
Liver Resection for Metastatic Colorectal Cancer in Patients with Concurrent Extrahepatic Disease: Results in 127 Patients Treated at a Single Center
Darren R. Carpizo et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Conversion to Resectability Using Hepatic Artery Infusion Plus Systemic Chemotherapy for the Treatment of Unresectable Liver Metastases From Colorectal Carcinoma
Nancy E. Kemeny et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Rates and Patterns of Recurrence Following Curative Intent Surgery for Colorectal Liver Metastasis An International Multi-Institutional Analysis of 1669 Patients
Mechteld C. de Jong et al.
ANNALS OF SURGERY (2009)
Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases
Anne M. Covey et al.
ANNALS OF SURGERY (2008)
Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome - Trends in treatment over time in 440 patients
Jason S. Gold et al.
ANNALS OF SURGERY (2008)
Meta-analysis of hepatic arterial infusion for unresectable liver Metastases from colorectal cancer: The end of an era?
Simone Mocellin et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Actual 10-year survival after resection of colorectal liver Metastases defines cure
James S. Tomlinson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases
Rene Adam et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2007)
Chemotherapy and regional therapy of hepatic colorectal metastases: Expert consensus statement
David L. Bartlett et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Selection of patients for resection of hepatic colorectal metastases: Expert consensus statement
Chusilp Charnsangavej et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Epidemiology and management of liver metastases from colorectal cancer
Sylvain Manfredi et al.
ANNALS OF SURGERY (2006)
Guidelines for resection of colorectal cancer liver metastases
O. J. Garden et al.
GUT (2006)
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: A randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)
NE Kemeny et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer
N Kemeny et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: An institutional experience of 544 consecutive cases
PJ Allen et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2005)
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases
TM Pawlik et al.
ANNALS OF SURGERY (2005)
Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model
R Dzodic et al.
ANTI-CANCER DRUGS (2004)
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases
EK Abdalla et al.
ANNALS OF SURGERY (2004)
Trends in long-term survival following liver resection for hepatic colorectal metastases
MA Choti et al.
ANNALS OF SURGERY (2002)
Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer
N Kemeny et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
